Regulatory › Drugs@FDA › History › NDA213051 Drugs@FDA application timeline
NDA213051 13 dated FDA-coded AP submissions from 2019-09-20 through 2026-01-30, connected to 18 source-defined action assignments and 28 official document links.
13 Dated AP submissions
18 Action assignments
28 Official documents
1 Exact enforcement reports
1 Reviewed profile mappings
Reporting boundary This history reports exact Drugs@FDA submission status dates, source-defined action labels, and official document metadata for applications already selected by PeptideScanner. FDA's AP code and action labels are source metadata; this page does not interpret approval scope, reproduce document text, establish safety or effectiveness, or provide medical guidance. Document links open FDA-hosted material; PeptideScanner does not copy or summarize their contents.
Reviewed identity mapping
Connected peptide profiles Reporting boundary This PeptideScanner lane is a bounded, dated FDA enforcement-report snapshot connected through an exact openFDA application-number annotation. It is not a medical alert or complete recall-lifecycle tracker, does not establish current product or recall status, does not identify affected lots, and does not provide medical guidance.
2021-06-02 · Class II · Terminated
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Open attributed report → Newest first
Submission and document chronology 13 submissions 2026-01-30 · status AP
Supplement 30 FDA action labels Labeling-Container/Carton Labels · Labeling-Medication Guide · Labeling-Package Insert
2 official documents Label ↗ 2026-07-31 · FDA document 84949 Letter ↗ 2026-02-03 · FDA document 84895 2025-10-17 · status AP
Supplement 29 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2025-10-21 · FDA document 83857 Label ↗ 2025-10-20 · FDA document 83832 2025-10-17 · status AP
Supplement 28 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2025-10-21 · FDA document 83856 Label ↗ 2025-10-20 · FDA document 83830 2025-10-17 · status AP
Supplement 24 FDA action labels Efficacy-New Indication
4 official documents 2024-12-09 · status AP
Supplement 21 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2025-02-11 · FDA document 80545 Letter ↗ 2024-12-10 · FDA document 80551 2024-12-09 · status AP
Supplement 20 FDA action labels Efficacy-New Dosing Regimen
2 official documents Label ↗ 2025-02-11 · FDA document 80546 Letter ↗ 2024-12-10 · FDA document 80550 2024-11-01 · status AP
Supplement 23 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Label ↗ 2024-11-05 · FDA document 80140 Letter ↗ 2024-11-05 · FDA document 80128 2024-01-24 · status AP
Supplement 18 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2024-01-25 · FDA document 77299 Letter ↗ 2024-01-25 · FDA document 77291 2023-01-12 · status AP
Supplement 12 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2023-01-13 · FDA document 73157 Letter ↗ 2023-01-13 · FDA document 73152 2022-06-10 · status AP
Supplement 11 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Letter ↗ 2022-06-14 · FDA document 71305 Label ↗ 2022-06-14 · FDA document 71296 2021-04-30 · status AP
Supplement 6 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
1 official document Label ↗ 2021-05-05 · FDA document 67412 2020-01-16 · status AP
Supplement 1 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Letter ↗ 2020-01-17 · FDA document 61603 Label ↗ 2020-01-17 · FDA document 61591 2019-09-20 · status AP
Original submission 1 No source action-type assignment was retained for this submission.
3 official documents Review ↗ 2020-06-10 · FDA document 63478 Letter ↗ 2019-09-24 · FDA document 60094 Label ↗ 2019-09-20 · FDA document 60077 Source archive dated 2026-08-24; observed 2026-08-24T21:23:49.000Z; reviewed 2026-08-24. Observation SHA-256: 6166fd223ef126a19e8ebfdaafe1fbf7c330a4cf7153cef00fb6c52c45ef757b.